Literature DB >> 20331474

Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Maria F Silva1, Alice O Kamphorst, Elize A Hayashi, Maria Bellio, Claudia R Carvalho, Ana M C Faria, Kátia C C Sabino, Marsen G P Coelho, Alberto Nobrega, Daniel Tavares, Antonio C Silva.   

Abstract

SUMMARY: Oral tolerance (OT) is being studied with great interest because of its therapeutic potential in allergy and autoimmunity. In the present study, two mouse strains with extreme phenotypes of OT susceptibility (TS) or resistance (TR) to ovalbumin (OVA) were used to demonstrate whether the tr and ts genes, cumulated during 18 generations of bi-directional genetic selection, influence expression of immunobiological traits in naive or antigen-gavaged TR/TS mice. The difference in anti-OVA titres was 2048-fold between OVA-gavaged TS and TR mice. Tolerance susceptibility to OVA gavage in individuals from a (TS x TR)F(2) population was 24% high-susceptibility, 62% low-susceptibility and 14% non-tolerant. Different antigens, unrelated to OVA, were tested by gavage and TS mice were generally susceptible while TR mice were resistant. The stability of TS and TR phenotypes was not affected by the use of strict protocols of intraperitoneal immunization or feeding over 30 consecutive days. The levels of interleukin-2 (IL-2), IL-4, interferon-gamma and IL-10 cytokines evaluated in concanavalin A-stimulated spleen cells from naive mice and in OVA-stimulated spleen cells from OVA-gavaged mice were higher in TS mice. Interleukin-10 was up-regulated in OVA-gavaged TS mice and down-regulated in TR mice. In naive mice, the percentage of CD4(+) CD25(+) and CD4(+) Foxp3(+) spleen cells and IL-10 expression by CD4(+) cells was significantly higher in TS mice. These results indicate that regulation of IL-10 expression could be an important factor contributing to the mechanisms controlling OT susceptibility, and that the OT responses of TR and TS individuals strongly correlate with their innate potential to secrete this cytokine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331474      PMCID: PMC2913224          DOI: 10.1111/j.1365-2567.2010.03248.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

Review 1.  Oral tolerance: mechanisms and therapeutic applications.

Authors:  A M Faria; H L Weiner
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  IL-4 and IL-10 are both required for the induction of oral tolerance.

Authors:  L V Rizzo; R A Morawetz; N E Miller-Rivero; R Choi; B Wiggert; C C Chan; H C Morse; R B Nussenblatt; R R Caspi
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

3.  Genetic selection for susceptibility to oral tolerance leads to a profound reduction of the acute inflammatory response.

Authors:  Maria de Fátima Sarro da Silva; Alberto da Nóbrega; Tereza Cristina Barja-Fidalgo; Aline C Brando-Lima; Fernando Cunha; Antonio Carlos da Silva
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

4.  Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease.

Authors:  Thomas A Kraus; Adam Cheifetz; Lisa Toy; Jonathan B Meddings; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2006-02       Impact factor: 5.325

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

Review 7.  Oral tolerance and TGF-beta-producing cells.

Authors:  Ana M C Faria; Howard L Weiner
Journal:  Inflamm Allergy Drug Targets       Date:  2006-09

8.  [Heterogeneity of corn seed glutelin: selective extraction and amino acid composition of the 3 isolated fractions].

Authors:  J Landry; T Moureaux
Journal:  Bull Soc Chim Biol (Paris)       Date:  1970

9.  Inflammatory lesion and parasite load are inversely associated in Leishmania amazonensis infected mice genetically selected according to oral tolerance susceptibility.

Authors:  Daniel Tavares; Ricardo da Conceição Ribeiro; Antonio Carlos da Silva
Journal:  Microbes Infect       Date:  2006-02-09       Impact factor: 2.700

10.  IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.

Authors:  J Inobe; A J Slavin; Y Komagata; Y Chen; L Liu; H L Weiner
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

View more
  3 in total

1.  Toxoplasma gondii oral infection induces intestinal inflammation and retinochoroiditis in mice genetically selected for immune oral tolerance resistance.

Authors:  Raul Ramos Furtado Dias; Eulógio Carlos Queiroz de Carvalho; Carla Cristina da Silva Leite; Roberto Carlos Tedesco; Katia da Silva Calabrese; Antonio Carlos Silva; Renato Augusto DaMatta; Maria de Fatima Sarro-Silva
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

2.  Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya.

Authors:  John Mokua Mose; David Muchina Kamau; John Maina Kagira; Naomi Maina; Maina Ngotho; Adele Njuguna; Simon Muturi Karanja
Journal:  Patholog Res Int       Date:  2017-05-24

3.  Participation of Leukotrienes in the Immune Modulation of Oral Tolerance.

Authors:  Sandra R P de Oliveira; Auro Nomizo; Fabiani G Frantz; Lúcia H Faccioli; Ana Paula Keller de Matos; Emanuel Carrilho; Ana Afonso; Fernanda de Freitas Anibal
Journal:  Front Microbiol       Date:  2017-02-21       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.